The IPO market is buzzing this week with strong demand and excitement. The Hamps Bio IPO, a marketing and distributing pharmaceutical products company opened its public issue on December 13.The bidding window for the Hamps Bio IPO will close on December 17.
Grey Market Premium Trends
The grey market premium (GMP) for Hamps Bio IPO has been on an upward trajectory. A day before the issue opened, the GMP was Rs 21, indicating a potential listing gain of 41 per cent.
But, now, as per the recent trends and day 2 of the subscription (December 16), the BSE SME issue GMP surged to Rs 40, projecting an estimated debut price of Rs 91 per share, translating to a listing gain of 78.43 per cent.
IPO overview
The Hamps Bio IPO has a total size of Rs 6.22 crores, with the entire issue consisting of a fresh offering of 12.2 lakh shares. It is a fixed price issue, with shares priced at Rs 51 each.
For retail investors, the minimum investment is Rs 1,02,000, which covers the purchase of 2,000 shares in one lot. For high-net-worth individuals (HNIs), the minimum investment requirement is Rs 2,04,000, which corresponds to two lots, or 4,000 shares.
“We have certain outstanding litigation against us, an adverse outcome of which may adversely affect our business,reputation and results of operations,” added Hamps Bio in the risk disclosure filed in the DRHP
“We do not have our own manufacturing facility for pharmaceutical products and we have to rely on third parties for procuring pharmaceutical products sold by our Company,” it further noted.
BSE SME Issue – Subscription Day 2
By 2:45 PM, the Hamps Bio IPO was subscribed 140.6 times overall on Day 2 so far. The retail category led the way with 249.19 times subscription, while non-institutional investors (NII) subscribed 31.93 times.
Also Read: Mobikwik IPO Allotment Live Updates: Check GMP price, Listing date, and other key details
Allotment and Listing
Allotment is expected to be finalised on Wednesday, December 18, and the stock is scheduled to debut on the BSE SME platform on Friday December 20.
Lead Managers and Registrar
The registrar for this IPO is Bigshare Service, while the lead manager handling the offering is Marwadi Chandarana Intermediaries Brokers. The market maker for the Hamps Bio IPO is Pure Broking.
(Disclaimer: Views, recommendations, opinions expressed are personal and do not reflect the official position or policy of Financial Express Online. Readers are advised to consult qualified financial advisors before making any investment decisions. Reproducing this content without permission is prohibited.)